Implantica
37.35
SEK
-4.23 %
IMP A SDB
First North Stockholm
Medical Equipment & Services
Health Care
1 following
-4.23%
-8.9%
-15.11%
+29.46%
+56.28%
+117.66%
-45.39%
-
-61.32%
www.implantica.com/investors
Implantica is active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes implantable medical instruments, which are further used for the treatment of diseases that affect the esophagus. In addition to the main business, service and related ancillary services are also offered, especially focused on eHealth. Implantica operates worldwide, with the largest presence in North America and Europe.
Revenue
15.7M
EBIT %
-1,548.94 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
IMP A SDB
Daily low / high price
37.35 / 39
SEK
Market cap
44.19B SEK
Turnover
970.57K SEK
Volume
26K
Latest videos
Financial calendar
Annual report
14.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Peter Forsell | 47.4 % | 47.4 % |
Handelsbanken Fonder | 8.6 % | 8.6 % |
EFG Bank | 7.1 % | 7.1 % |
UBP | 2.8 % | 2.8 % |
Avanza Pension | 2.6 % | 2.6 % |
SEB Life | 2.3 % | 2.3 % |
UBS | 2.1 % | 2.1 % |
TIN Fonder | 1.7 % | 1.7 % |
SIX SIS AG | 1.5 % | 1.5 % |
Stephan Siegenthaler | 1.3 % | 1.3 % |
ShowingAll content types
Implantica publishes Interim Report January - September 2024 (Q3)
Implantica submits FDA PMA application Clinical Module 2 for RefluxStop™ for U.S. market approval
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools